Efficiency of application of radiation techniques to treat patients with localized prostate cancer in one hospita

Objectives. Analyzed short-and long-term results of radiation therapies (brachytherapy ¹²⁵I, conformal radiation therapy, stereotactic robotic radiotherapy) of patients with prostate cancer.

Materials and methods. In each treatment the patients were divided into 2 groups received the combined treatment in combination with neoadjuvant hormone therapy without its implementation. The immediate results of treatment were assessed according to the level of total prostatic specific antigen, prostate volume, residual urine, change according to the International Prostatic Symptom Score (IPSS).

Results. The dynamics of these indicators comparable in both groups, which is reflected in the regression of the primary tumor, as well as the quality of life of patients. Five-year overall survival and oncospecific survival in the group of patients after stereotactic radiotherapy is 100 %, the remaining groups – of more than 90–95 %.

Conclusion. The obtained results testify to the effectiveness of the proposed methods of treatment of patients with localized prostate cancer. 

1. Зырянов А.В., Баженов А.А., Машковцев А.В. Брахитерапия в лечении больных локализованным раком предстательной железы с доброкачественной гиперплазией предстательной железы. Уральский медицинский журнал 2009;11(65):35–6. [Zyryanov A.V., Bazhenov A.A., Mashkovtsev A.V. Brachytherapy in treatment of patients with localized prostate cancer and benign prostatic hyperplasia. Ural’skiy meditsinskiy zhurnal = Ural Medical Journal 2009;11(65):35–6. (In Russ.)].

2. Состояние онкологической помощи населению России в 2009 году. Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГУ «МНИОИ им. П.А. Герцена Росмедтехнологий», 2010. 196 с. [State of oncological care in Russia in 2009. Eds.: V.I. Chissov, V.V. Starinskiy, G.V. Petrova. Moscow: FGU “MNIOI im. P.A. Gertzena Rosmedtekhnologiy”, 2010. 196 p. (In Russ.)].

3. Злокачественные новообразования в России в 2009 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГУ «МНИОИ им. П.А. Герцена Минздравсоцразвития России», 2011. 260 с. [Malignant neoplasms in Russia in 2009 (morbidity and mortality). Eds.: V.I. Chissov, V.V. Starinskiy, G.V. Petrova. Moscow: FGU “MNIOI im. P.A. Gertzena Rosmedtekhnologiy”, 2011. 260 p. (In Russ.)].

4. Важенин А.В., Карнаух П.А. Эпидемиология рака предстательной железы в Челябинской области. Паллиативная медицина и реабилитация 2008;(2): 26–8. [Vazhenin A.V., Karnaukh P.A. Epidemiology of prostate cancer in Chelyabinsk Region. Palliativnaya meditsina i reabilitatsiya = Palliative Medicine and Rehabilitation 2008;(2): 26–8. (In Russ.)].

5. Katz A.J., Kang J. Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study. Front Oncol 2014;4:301. DOI: 10.3389/fonc.2014.00301. PMID: 25389521.

6. Katz A.J., Kang J. Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study. Front Oncol 2014;4:240. DOI: 10.3389/fonc.2014.00240. PMID: 25229051.

7. Sanfilippo N.J., Cooper B.T. Hypofractionated radiation therapy for prostate cancer: biologic and technical considerations. Am J Clin Exp Urol 2014;2(4):286–93. PMID: 25606574.